Medical Innovation Exchange

Pfizer snaps up rights to RSV therapy left behind in ReViral buy for $20M

https://www.fiercebiotech.com/biotech/pfizer-puts-20m-rights-lianbio-rsv-program-greater-china

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!